ANDROGENETIC ALOPECIA

This study tested a minoxidil tablet placed under the tongue (2.5 mg twice daily) in 142 men with male pattern baldness. The goal was to see if it increases hair count on the scalp over 24 weeks compared to a placebo. The trial is complete, and results focus on safety and hair gr…

This study tested whether using a mix of povidone-iodine and rifampicin on the scalp before hair transplant surgery helps wounds heal faster and prevents infections better than using povidone-iodine alone. 65 adults having hair transplants were randomly assigned to get either the…

This study tested a gel called PP405 for male and female pattern baldness. 78 adults used the gel or a placebo for 28 days, then everyone could use the real gel for 3 more months. The main goals were to check safety and how the body processes the drug.

This study tested a special mineral-ionic formula called THERAVEX REGENERA in 20 adults with hair loss. The treatment was used during hair transplant procedures and as a scalp therapy to help hair follicles grow back. Researchers checked safety and measured changes in hair densit…

This early-stage study tested a new gel called AH-001 on 64 healthy volunteers and men with male pattern baldness. The main goal was to see if the gel is safe and how the body processes it at different strengths. No information on whether it actually regrows hair was collected.

This study tested whether a special shampoo can help reduce hair loss in adults with telogen effluvium or mild androgenetic alopecia. Forty participants used the shampoo for three months. Researchers measured changes in hair length and thickness to see if the product worked.